Phase I trial of intraperitoneal taxol: A gynecoloic oncology group study Academic Article uri icon

Overview

MeSH Major

  • Alkaloids
  • Antineoplastic Agents, Phytogenic
  • Ovarian Neoplasms
  • Peritoneal Neoplasms

abstract

  • Taxol can be delivered by the IP route with both an acceptable toxicity profile and a major pharmacokinetic advantage for cavity exposure.

publication date

  • December 1992

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 1355523

Additional Document Info

start page

  • 1485

end page

  • 91

volume

  • 10

number

  • 9